Limited Liability Company "PHARMENTERPRISES";製藥有限責任公司;制药有限责任公司
发明人:
NEBOLSIN, Vladimir Evgenievich,弗拉迪米尔．叶夫根尼耶维奇．涅博利辛,弗拉迪米爾．葉夫根尼耶維奇．涅博利辛,BORISEVICH, Sergei Vladimirovich,谢尔盖．弗拉基米罗维奇．鲍里谢维奇,謝爾蓋．弗拉基米羅維奇．鮑里謝維奇,EGOROV, Andrei Yurievich,安德烈．尤里耶维奇．叶戈罗夫,安德烈．尤里耶維奇．葉戈羅夫,弗拉迪米尔.叶夫根尼耶维奇.涅博利辛,弗拉迪米爾.葉夫根尼耶維奇.涅博利辛,谢尔盖.弗拉基米罗维奇.鲍里谢维奇,謝爾蓋.弗拉基米羅維奇.鮑里謝維奇,安德烈.尤里耶维奇.叶戈罗夫,安德烈.尤里耶維奇.葉戈羅夫
申请号：
MOJ003087
公开号：
MOJ003087B
申请日:
2018.05.14
申请国别(地区):
MO
年份:
2018
代理人:
摘要：
The present invention relates to medicine and it is related to preventing or treating the method for the disease as caused by the virus for containing (+) RNA with what, the method includes using a effective amount of glutaryl histamine or its officinal salt. The invention further relates to preventing or treating the pharmaceutical composition of the disease as caused by the virus containing (+) RNA with what, it includes a effective amount of glutaryl histamine or its officinal salts. The present invention solves the problems, such as to provide the effective new medicament in treating the disease as caused by the virus containing (+) RNA of enterovirus genus or Flavivirus.本發明涉及醫學並涉及用於預防或治療由含有(+)RNA之病毒引起的疾病的方法，所述方法包括使用有效量的戊二酸單酰組胺或其可藥用鹽。本發明還涉及用於預防或治療由含有(+)RNA之病毒引起的疾病的藥物組合物，其包含有效量的戊二酸單酰組胺或其可藥用鹽。本發明解决了提供在治療由腸道病毒屬或黃病毒屬的含有(+)RNA之病毒引起的疾病中有效的新藥劑的問題。
